PYGB Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P11216 |
---|---|
Clone Names | 100427038 |
Gene ID | 5834 |
---|---|
Other Names | Glycogen phosphorylase, brain form, PYGB |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13699a was selected from the N-term region of PYGB. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | PYGB {ECO:0000303|PubMed:3346228} |
---|---|
Function | Glycogen phosphorylase that regulates glycogen mobilization (PubMed:27402852). Phosphorylase is an important allosteric enzyme in carbohydrate metabolism (PubMed:3346228). Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates (PubMed:3346228). However, all known phosphorylases share catalytic and structural properties (PubMed:3346228). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is a glycogenphosphorylase found predominantly in the brain. The encoded proteinforms homodimers which can associate into homotetramers, theenzymatically active form of glycogen phosphorylase. The activityof this enzyme is positively regulated by AMP and negativelyregulated by ATP, ADP, and glucose-6-phosphate. This enzymecatalyzes the rate-determining step in glycogen degradation.
References
Pudil, R., et al. Clin. Chem. Lab. Med. 48(8):1193-1195(2010)Martins-de-Souza, D., et al. J Psychiatr Res (2010) In press :Yoshida, T., et al. Int. J. Mol. Med. 25(4):649-656(2010)Oguri, M., et al. Am. J. Hypertens. 23(1):70-77(2010)Chapuis, J., et al. Mol. Psychiatry 14(11):1004-1016(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.